Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2013 Mar;39(2):266-7.
doi: 10.1093/schbul/sbs134. Epub 2012 Nov 15.

Diabetes or prediabetes in newly diagnosed patients with nonaffective psychosis? A historical and contemporary view

Emilio Fernandez-Egea  1 , Clemente Garcia-Rizo, Jorge Zimbron, Brian Kirkpatrick
Affiliations
Comment

Diabetes or prediabetes in newly diagnosed patients with nonaffective psychosis? A historical and contemporary view

Emilio Fernandez-Egea et al. Schizophr Bull. 2013 Mar.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Mitchell AJ, Vancampfort D, De Herdt A, Yu W, De Hert M. Is the prevalence of metabolic syndrome and metabolic abnormalities increased in early schizophrenia? A comparative meta-analysis of first episode, untreated and treated patients [published online ahead of print August 27, 2012] Schizophr Bull doi:10.1093/schbul/sbs082 - PMC - PubMed
    1. Lorenz WF. Sugar tolerance in dementia praecox and other mental disorders Arch Neurol Psychiatry 1922. 8 184–196
    1. Cohn TA, Remington G, Zipursky RB, Azad A, Connolly P, Wolever TM. Insulin resistance and adiponectin levels in drug-free patients with schizophrenia: a preliminary report. Can J Psychiatry 2006. 51 382–386 - PubMed
    1. Spelman LM, Walsh PI, Sharifi N, Collins P, Thakore JH. Impaired glucose tolerance in first-episode drug-naïve patients with schizophrenia. Diabet Med 2007. 24 481–485 - PubMed
    1. Saddichha S, Manjunatha N, Ameen S, Akhtar S. Diabetes and schizophrenia—effect of disease or drug? Results from a randomized, double-blind, controlled prospective study in first- episode schizophrenia. Acta Psychiatr Scand 2008. 117 342–347 - PubMed

Substances